GZ402668

GZ402668 · Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GZ402668, covering 2016-04-13 to 2016-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis [Phase 1]

See pricing